Ravenquest Biomed Financials
We recommend to use Ravenquest Biomed fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Ravenquest Biomed as well as the relationship between them. We were able to break down and collect data for twenty-six available financial ratios for Ravenquest Biomed, which can be compared to its competitors.
Ravenquest |
Ravenquest Biomed Stock Summary
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | CA7543871080 |
| Business Address | 580 Hornby Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.rqbglobal.com |
| Phone | 877 282 1586 |
| Currency | USD - US Dollar |
Ravenquest Biomed Key Financial Ratios
There are many critical financial ratios that Ravenquest Biomed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ravenquest Biomed reports annually and quarterly.| Return On Equity | -1.12 | |||
| Return On Asset | -0.19 | |||
| Number Of Employees | 15 | |||
| Beta | -79.79 |
Ravenquest Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ravenquest Biomed's current stock value. Our valuation model uses many indicators to compare Ravenquest Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ravenquest Biomed competition to find correlations between indicators driving Ravenquest Biomed's intrinsic value. More Info.Ravenquest Biomed is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ravenquest Biomed's earnings, one of the primary drivers of an investment's value.Ravenquest Biomed Systematic Risk
Ravenquest Biomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ravenquest Biomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Ravenquest Biomed correlated with the market. If Beta is less than 0 Ravenquest Biomed generally moves in the opposite direction as compared to the market. If Ravenquest Biomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ravenquest Biomed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ravenquest Biomed is generally in the same direction as the market. If Beta > 1 Ravenquest Biomed moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Ravenquest Pink Sheet analysis
When running Ravenquest Biomed's price analysis, check to measure Ravenquest Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ravenquest Biomed is operating at the current time. Most of Ravenquest Biomed's value examination focuses on studying past and present price action to predict the probability of Ravenquest Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ravenquest Biomed's price. Additionally, you may evaluate how the addition of Ravenquest Biomed to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |